199 related articles for article (PubMed ID: 6133321)
21. Analysis of pentagastrin and calcium as thyrocalcitonin secretagogues in the early diagnosis of medullary carcinoma of the thyroid gland.
Linehan WM; Farrell RE; Cooper CW; Wells SA
Surg Forum; 1977; 28():110-2. PubMed ID: 617389
[No Abstract] [Full Text] [Related]
22. [Medullary carcinoma of the thyroid gland].
Zarrilli L; Marzano LA; Porcelli A; Zarrilli S; D'Ajello M
Chir Ital; 1994; 46(4):33-6. PubMed ID: 7882440
[TBL] [Abstract][Full Text] [Related]
23. [Clinical signs in medullary cancers of the thyroid].
Delisle MJ; Gardet P; Laplanche A; Rougier P; Parmentier C
Bull Cancer; 1984; 71(3):165-71. PubMed ID: 6148974
[TBL] [Abstract][Full Text] [Related]
24. Medullary thyroid carcinoma in Sipple syndrome.
Johns Hopkins Med J; 1979 Nov; 145(5):201-6. PubMed ID: 41125
[No Abstract] [Full Text] [Related]
25. [Calcitonin as a tumor marker. I. Medullary carcinoma of the thyroid].
Galán Galán F; Garrido Peralta M
Rev Clin Esp; 1982 Apr; 165(1):5-9. PubMed ID: 7122936
[No Abstract] [Full Text] [Related]
26. [Calcitonin and its significance for the diagnosis of medullary carcinoma of the thyroid].
Gautvik KM
Tidsskr Nor Laegeforen; 1973 May; 93(15):1143-8. PubMed ID: 4584540
[No Abstract] [Full Text] [Related]
27. Medullary thyroid cancer in a Wisconsin kindred with Sipple's syndrome: the use of provoked calcitonin testing.
Witte RS; Starling JR; Warner T; Davis TE
Wis Med J; 1982 Nov; 81(11):22-5. PubMed ID: 6130656
[No Abstract] [Full Text] [Related]
28. [MEN 2A syndrome: report of a family].
Krassowski J; Gabryelewicz MB; Jeske W; Zgliczyński S
Pol Merkur Lekarski; 2000 Jul; 8(49):481-2. PubMed ID: 11070721
[TBL] [Abstract][Full Text] [Related]
29. Radioactive iodine treatment in medullary thyroid carcinoma.
Faik Erdogan M; Gursoy A; Erdogan G; Kamel N
Nucl Med Commun; 2006 Apr; 27(4):359-62. PubMed ID: 16531922
[TBL] [Abstract][Full Text] [Related]
30. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
[TBL] [Abstract][Full Text] [Related]
31. Medullary carcinoma of the thyroid gland.
Sizemore GW
Semin Oncol; 1987 Sep; 14(3):306-14. PubMed ID: 2888195
[No Abstract] [Full Text] [Related]
32. [Apudomatosis and medullary cancer of the thyroid: histopathogenic, genetic and clinical data, based on a case of thyroid cancer with amyloid stroma].
Attali JP
Rev Laryngol Otol Rhinol (Bord); 1979; 100(9-10):575-81. PubMed ID: 523869
[No Abstract] [Full Text] [Related]
33. Medullary carcinoma of the thyroid. An update of diagnostic and prognostic factors.
Gautvik KM
Scand J Clin Lab Invest Suppl; 1991; 206():85-92. PubMed ID: 1947764
[TBL] [Abstract][Full Text] [Related]
34. C-cell hyperplasia preceding medullary thyroid carcinoma.
Wolfe HJ; Melvin KE; Cervi-Skinner SJ; Saadi AA; Juliar JF; Jackson CE; Tashjian AH
N Engl J Med; 1973 Aug; 289(9):437-41. PubMed ID: 4587234
[No Abstract] [Full Text] [Related]
35. Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients.
Saad MF; Ordonez NG; Rashid RK; Guido JJ; Hill CS; Hickey RC; Samaan NA
Medicine (Baltimore); 1984 Nov; 63(6):319-42. PubMed ID: 6503683
[TBL] [Abstract][Full Text] [Related]
36. Clinical value of calcitonin and carcinoembryonic antigen doubling times in medullary thyroid carcinoma.
Jackson CE; Norum RA; Talpos GB; Feldkamp CS; Tashjian AH
Henry Ford Hosp Med J; 1987; 35(2-3):120-1. PubMed ID: 2891643
[No Abstract] [Full Text] [Related]
37. [Therapy of medullary thyroid carcinoma].
Raue F
Dtsch Med Wochenschr; 1985 Aug; 110(35):1337-9. PubMed ID: 2992904
[No Abstract] [Full Text] [Related]
38. Combining provocative agents of calcitonin to detect medullary carcinoma of the thyroid.
Sisson JC; Gross MD; Frietas JE; Jackson CE; England BG
Henry Ford Hosp Med J; 1981; 29(2):75-80. PubMed ID: 7263287
[No Abstract] [Full Text] [Related]
39. [Image analysis DNA cytometry in medullary thyroid gland cancer. Comparison with histomorphologic parameters and prognostic effect].
Böttger T; Potratz D; Gabbert H; Schernus B; Stöckle M; Klupp J; Junginger T
Chirurg; 1993 Feb; 64(2):122-9. PubMed ID: 8096455
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemistry in medullary thyroid carcinoma: prognosis and distinction between hereditary and sporadic tumors.
Franc B; Caillou B; Carrier AM; Dutrieux-Berger N; Floquet J; Houcke M; Justrabo E; Lange F; Pages A; Rigaud C
Henry Ford Hosp Med J; 1987; 35(2-3):139-42. PubMed ID: 2891646
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
